|
2025
|
Invention
|
Methods and products for transfecting cells.
The present invention relates in part to nucleic ac... |
|
|
Invention
|
Methods and products for expressing proteins in cells.
The present invention relates in part to ... |
|
|
Invention
|
Cationic lipids and transfection methods.
The present invention relates in part to novel cationi... |
|
|
Invention
|
Cationic lipids and uses thereof.
The present invention relates in part to novel cationic lipids... |
|
|
Invention
|
Engineered cells and uses thereof. The present disclosure provides engineered induced pluripotent... |
|
|
Invention
|
Methods and products for transfection.
The present invention relates in part to methods for prod... |
|
|
Invention
|
Nucleic acid-based therapeutics.
The present invention relates in part to nucleic acids, includi... |
|
2024
|
Invention
|
Methods and products for nucleic acid production and delivery.
The present invention relates in ... |
|
|
Invention
|
Cells and methods for engineering cells with persistent transgene expression. Aspects of the pres... |
|
|
Invention
|
Methods for reprogramming and gene editing cells. The present disclosure provides improved method... |
|
|
Invention
|
Multivalent ionizable lipid delivery systems. The present disclosure relates in part to cationic ... |
|
2023
|
Invention
|
Circular rna.
The present disclosure relates, in part, to circular RNAs and engineered variants ... |
|
|
Invention
|
Engineered immune cell therapies.
The present disclosure relates in part to engineered immune ce... |
|
|
Invention
|
Cationic lipids and transfection methods. The present invention relates in part to novel cationic... |
|
|
Invention
|
Methods and products for transfecting cells. The present invention relates in part to nucleic aci... |
|
|
Invention
|
Nucleic acid products and methods of administration thereof.
The present invention relates in pa... |
|
2022
|
Invention
|
Mesenchymal stem cell therapies.
Cell-based therapies based on mesenchymal stem cells (MSCs) are... |
|
|
Invention
|
Engineered gene-editing proteins.
The present invention relates in part to nucleic acids encodin... |
|
|
Invention
|
Methods and products for transfection. The present invention relates in part to methods for produ... |
|
|
Invention
|
Circular rna. Nucleic acid structures that promote formation of circular RNAs (circRNAs), which m... |
|
|
Invention
|
Engineered immune cell therapies. The present disclosure relates in part to engineered immune cel... |
|
2021
|
Invention
|
Engineered gene-editing proteins. The present invention relates in part to nucleic acids encoding... |
|
|
Invention
|
Mesenchymal stem cell therapies. Cell-based therapies based on mesenchymal stem cells (MSCs) are ... |
|
2020
|
Invention
|
Nucleic acid products and methods of administration thereof. The present invention relates in par... |
|
|
Invention
|
Cationic lipids and uses thereof. The present invention relates to novel cationic lipids of formu... |
|
|
Invention
|
Methods and products for expressing proteins in cells. The present invention relates in part to n... |
|
2019
|
Invention
|
Methods and products for nucleic acid production and delivery. The present invention relates in p... |
